MYC and retinoblastoma: In summary, our study identifies a regulatory axis NRMT/CENPA/Myc/Bcl2 implicated in the resistance to CDDP in retinoblastoma cells, which contributes to the comprehensive understanding of molecules and pathways that control CDDP-induced apoptosis (Fig. 7).